1-(2,4-dichlorobenzyl)indazole-3-carboxylic acid,
AF 1890,
diclondazolic acid,
lonidamine,
lonidamine,
50264-69-2,
Diclondazolic acid,
1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid,
Doridamina,
Lonidamina,
Lonidaminum,
Lonidamin,
AF 1890,
Lonidaminum [INN-Latin],
Lonidamina [INN-Spanish],
1-[(2,4-dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid,
1-(2,4-Dichlorbenzyl)-indazole-3-carboxylic acid,
UNII-U78804BIDR,
CCRIS 3516,
1-(2,4-dichlorobenzyl)indazole-3-carboxylic acid,
1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid,
EINECS 256-510-0,
AF-1890,
BRN 0894483,
C15H10Cl2N2O2,
MLS000028822,
U78804BIDR,
CHEBI:50138,
MFCD00866285,
NCGC00015609-03,
SMR000058467,
1H-Indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)-,
1H-Indazole-3-carboxylic acid, 1-[(2,4-dichlorophenyl)methyl]-,
DSSTox_CID_782,
DSSTox_RID_75787,
DSSTox_GSID_20782,
Q-201318,
1H-Indazole-3-carboxylic acid, 1-(2,4-dichlorobenzyl)-,
1H-Indazole-3-carboxylicacid, 1-[(2,4-dichlorophenyl)methyl]-,
Lonidamine [BAN:INN],
Doridamina (TN),
Dichlondazolic acid,
Lonidamine (INN),
CAS-50264-69-2,
Lonidamine [INN:BAN],
SR-01000075961,
KN-228,
TH-070,
Tocris-1646,
Lopac-L-4900,
L 4900,
AC1L21YG,
SCHEMBL7134,
Lopac0_000718,
cid_39562,
ZINC1632,
CHEMBL1257030,
DTXSID5020782,
BDBM59775,
CTK1H1686,
KS-00000XLL,
BIL0844,
WDRYRZXSPDWGEB-UHFFFAOYSA-N,
ZX-AFC001293,
HMS2234H24,
HMS3262O17,
HMS3268K09,
HMS3369I01,
HMS3651F09,
HMS3676P05,
Pharmakon1600-01503225,
ACT02617,
BCP06555,
HY-B0486,
Tox21_110181,
Tox21_202306,
Tox21_500718,
AF1890,
NSC741419,
NSC758419,
s2610,
AKOS012842739,
Tox21_110181_1,
AC-5626,
API0003207,
CCG-204803,
CS-2602,
LP00718,
LS-7474,
NSC-741419,
NSC-758419,
NCGC00015609-01,
NCGC00015609-02,
NCGC00015609-04,
NCGC00015609-05,
NCGC00015609-06,
NCGC00015609-07,
NCGC00015609-08,
NCGC00015609-09,
NCGC00025244-01,
NCGC00025244-02,
NCGC00025244-03,
NCGC00259855-01,
NCGC00261403-01,
AJ-08062,
AN-10756,
AS-11653,
BC213253,
BR-73119,
SC-75962,
SBI-0050696.P002,
AB0010495,
AB2000699,
AX8006155,
ST2414921,
TR-017970,
4CH-014644,
AM20060642,
EU-0100718,
FT-0650359,
SW219810-1,
Lonidamine, mitochondrial hexokinase inhibitor,
D07257,
J90044,
S-4929,
AB00597141_08,
AB00597141_10,
264L692,
I01-0912,
SR-01000075961-1,
SR-01000075961-3,
SR-01000075961-6,
BRD-K78513633-001-03-3,
BRD-K78513633-001-06-6,
1-(2,4-dichlorobenzyl)-1-H-indazole-3-carboxylic acid,
Z1741977188,
1-[(2,4-dichlorophenyl)methyl]-3-indazolecarboxylic acid,
1-[(2,4-DICHLOROPHENYL)METHYL]-1H-INDAZOLE-3-CARBO,
1H-Indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)- (9CI),
DICA,
null,
D09SIR,
CID39562,
C15-H10-Cl2-N2-O2,
B1964,
5-25-04-00250 (Beilstein Handbook Reference),
C016371,
Lonidamine, 99%, mitochondrial hexokinase inhibitor - 1G 1g,
1H-Indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)-(9CI),